---
figid: PMC6537282__10.1177_1756284819853208-fig1
figlink: /pmc/articles/PMC6537282/figure/fig1-1756284819853208/
number: Figure 1
caption: 'The JAK-STAT signaling pathway is involved in several processes.This figure
  was made with Servier Medical Art templates, which are licensed under a Creative
  Commons Attribution 3.0 Unported License: https://smart.servier.com.The presence
  of the ligand leads to receptor dimerization. Subsequently, JAK transphosphorylation
  takes place which allows for STAT recruitment and phosphorylation. Once phosphorylated,
  STATs will make dimers, which will translocate and promote transcription in the
  nucleus. Different JAK combinations will lead to different effects. Several JAK
  inhibitors are being studied in inflammatory bowel disease.EPO, erythropoietin;
  GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL, interleukin;
  JAK, Janus kinase; P, phosphorylated; STAT, signal transducer and activator of transcription
  protein; TPO, thrombopoietin.'
pmcid: PMC6537282
papertitle: 'New biologics and small molecules in inflammatory bowel disease: an update.'
reftext: Jo√£o Sabino, et al. Therap Adv Gastroenterol. 2019;12:1756284819853208.
pmc_ranked_result_index: '45447'
pathway_score: 0.8439509
filename: 10.1177_1756284819853208-fig1.jpg
figtitle: 'New biologics and small molecules in inflammatory bowel disease: an update.'
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6537282__10.1177_1756284819853208-fig1.html
  '@type': Dataset
  description: 'The JAK-STAT signaling pathway is involved in several processes.This
    figure was made with Servier Medical Art templates, which are licensed under a
    Creative Commons Attribution 3.0 Unported License: https://smart.servier.com.The
    presence of the ligand leads to receptor dimerization. Subsequently, JAK transphosphorylation
    takes place which allows for STAT recruitment and phosphorylation. Once phosphorylated,
    STATs will make dimers, which will translocate and promote transcription in the
    nucleus. Different JAK combinations will lead to different effects. Several JAK
    inhibitors are being studied in inflammatory bowel disease.EPO, erythropoietin;
    GM-CSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; IL,
    interleukin; JAK, Janus kinase; P, phosphorylated; STAT, signal transducer and
    activator of transcription protein; TPO, thrombopoietin.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - JAK1
  - JAK2
  - TYK2
  - IFNA1
  - IL15
  - IL20
  - IL21
  - IL10
  - IL2
  - IL4
  - IL9
  - IFNL1
  - JAK3
  - EPO
  - TPO
  - CSF2
  - IL27
  - STAT5A
  - STAT6
  - IL7
  - STAT1
  - STAT5B
  - STAT4
  - STAT2
  - STAT3
  - Tofacitinib
  - Upadacitinib
  - Filgotinib
genes:
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: IFN-a,
  symbol: IFN-ALPHA
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: IL-15,IL-21
  symbol: IL-15
  source: hgnc_alias_symbol
  hgnc_symbol: IL15
  entrez: '3600'
- word: IL-20,
  symbol: IL20
  source: hgnc_symbol
  hgnc_symbol: IL20
  entrez: '50604'
- word: IL-21
  symbol: IL21
  source: hgnc_symbol
  hgnc_symbol: IL21
  entrez: '59067'
- word: IL-10,
  symbol: IL-10
  source: hgnc_alias_symbol
  hgnc_symbol: IL10
  entrez: '3586'
- word: IL-2,IL-4,IL-7,IL-9,
  symbol: IL-2
  source: hgnc_alias_symbol
  hgnc_symbol: IL2
  entrez: '3558'
- word: IL-4,
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: IL-9,
  symbol: IL-9
  source: hgnc_alias_symbol
  hgnc_symbol: IL9
  entrez: '3578'
- word: IL-29
  symbol: IL-29
  source: hgnc_alias_symbol
  hgnc_symbol: IFNL1
  entrez: '282618'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: EPO,
  symbol: EPO
  source: hgnc_symbol
  hgnc_symbol: EPO
  entrez: '2056'
- word: IFN-
  symbol: IFN
  source: hgnc_alias_symbol
  hgnc_symbol: IFNA1
  entrez: '3439'
- word: OOEPO,TPO,GM-CSF
  symbol: TPO
  source: hgnc_symbol
  hgnc_symbol: TPO
  entrez: '7173'
- word: OOEPO,TPO,GM-CSF
  symbol: GM-CSF
  source: hgnc_alias_symbol
  hgnc_symbol: CSF2
  entrez: '1437'
- word: JAK3
  symbol: JAK3
  source: hgnc_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JoIFN-y,IL-27,IL-35
  symbol: IL27
  source: hgnc_symbol
  hgnc_symbol: IL27
  entrez: '246778'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: IL-7,
  symbol: IL-7
  source: hgnc_alias_symbol
  hgnc_symbol: IL7
  entrez: '3574'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
chemicals:
- word: Tofacitinib
  source: MESH
  identifier: C479163
- word: Upadacitinib
  source: ''
  identifier: ''
- word: Filgotinib
  source: ''
  identifier: ''
diseases: []
---
